The present study indicated that TCM would affect PTGS1, PTGS2, RXRA, CHRM1, and NOS2 targets via network pharmacology to prevent and regulate AD, which might provide a beneficial path for future investigations on TCM in AD. This evidence concerns the gene CHRM1 and Alzheimer disease.